# SLU-PP-332

> A synthetic small-molecule pan-ERR agonist studied as an “exercise mimetic” — not a peptide.

- Also known as: SLU PP 332
- Class: Metabolic, Mitochondrial
- FDA approved: No
- Canonical page: https://americanpeptide.com/catalog/slu-pp-332

## Overview

SLU-PP-332 is a synthetic small molecule — not a peptide — that activates all three estrogen-related receptors (ERRα, ERRβ, ERRγ), the orphan nuclear receptors that control oxidative metabolism and mitochondrial biogenesis. It is studied as an “exercise mimetic”: in preclinical work it increased a type of muscle fiber and oxidative metabolism and reduced fat mass in mice without changes in food intake or activity. It is an early research compound with no human data and no approval.

SLU-PP-332 came out of medicinal-chemistry work (Burris and colleagues) to find a direct agonist of the estrogen-related receptors, which sit downstream of PGC-1α and govern how cells build mitochondria and burn fat. Activating that program pharmacologically is the idea behind an “exercise mimetic” — reproducing some transcriptional effects of endurance exercise without the exercise.

In mouse studies the compound raised oxidative (fatigue-resistant) muscle fiber content and energy expenditure and reduced fat mass and diet-induced obesity. All of this is preclinical: there is no clinical trial, no safety data in humans, and it is a research chemical rather than a peptide or an approved drug.

## Mechanism

Pan-ERR (ERRα/β/γ) agonism, upregulating the PGC-1α/ERR transcriptional program for mitochondrial biogenesis, fatty-acid oxidation, and oxidative muscle metabolism.

## Research areas

Studied in: Mitochondrial biogenesis, Obesity (preclinical), Exercise mimetic research, Oxidative metabolism.

Guides on this site:

- [Weight Loss & Metabolic Health](https://americanpeptide.com/research-areas/weight-loss): Incretin and metabolic peptides studied for glycemic control and fat loss.
- [Mitochondrial & Bioenergetics](https://americanpeptide.com/research-areas/mitochondrial): Mitochondria-targeted peptides studied for bioenergetics and cardiolipin.

## Key research

- Pan-ERR agonist — directly activates ERRα/β/γ, the receptors downstream of PGC-1α that drive mitochondrial and oxidative metabolism.
- Exercise-mimetic phenotype — increased oxidative muscle fiber and energy expenditure in mice.
- Fat-mass reduction — reduced diet-induced obesity in mice without changes in food intake.
- Small molecule, preclinical — not a peptide; no human data and not FDA-approved.

## Storage, handling & synthesis

**Storage.** As a small molecule rather than a peptide, store per the compound’s own stability — typically cool, dry, and light-protected; reconstitution depends on its solvent, not on peptide practice.

**Handling.** Handle by organic-chemistry practice: dissolve in the appropriate solvent, and verify identity and purity by HPLC with NMR or mass spectrometry rather than a peptide-style certificate.

**Synthesis.** Not a peptide — a synthetic small molecule made by conventional organic synthesis. Its purity and identity are an organic-chemistry question answered by HPLC and NMR/mass spectrometry, not by peptide solid-phase synthesis or a peptide-style certificate. Vendor material described with a peptide CoA is a red flag that the wrong analysis was run.

## FAQs

### What is SLU-PP-332?

A synthetic small-molecule agonist of the estrogen-related receptors (ERRα/β/γ), studied as an exercise mimetic that boosts oxidative metabolism in preclinical models. It is not a peptide.

### Why is it called an exercise mimetic?

It activates the PGC-1α/ERR transcriptional program that endurance exercise normally engages — mitochondrial biogenesis and fat oxidation — pharmacologically rather than through exercise.

### Is there human data?

No. The published work is in mice; there is no clinical trial or human safety data.

### Is it approved?

No — it is an early research compound, not FDA-approved. This page is a research and educational reference.

---

Source: AmericanPeptide.com — https://americanpeptide.com/catalog/slu-pp-332
Data license: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Attribution: AmericanPeptide.com.
Research reference only — computational and educational content, not medical advice.